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Objective: To assess the effect of Helicobacter pylori 
(HP) eradication on the proliferation of the gastric 
epithelium by the expression of the proliferating cell 
nuclear antigen (PCNA). Methods: Alcohol-fixed gas-
tric biopsies taken before and after treatment for HP 
were immunostained with the PC-10 anti-PCNA mono-
clonal antibody and the labeling index was determined 
with an image analysis system. Results: The mean 
PCNA-labeling index (LI) of 16 patients who remained 
HP positive did not change significantly (18.95 ± 1.71 
on first visit vs. 17.96 ± 1.91 on second visit, mean ± 
SEM). The mean PCNA LI of 31 patients who cleared 
HP was reduced significantly (19.95 ± 1.77 on first 
visit vs. 14.13 ± 1.29 on second visit, p < 0.001). 
Patients who were positive for HP at both first and 
second visit showed a significantly higher PCNA LI 
than normal control biopsies (13.05 ± 1.70) (p < 0.05). 
Conclusions: These results indicate that the gastric 
mucosa infected with HP is in a state of hyperprolifer-
ation. Patients who cleared HP showed a significant 
histopathological improvement, reflected in the reduc-
tion in number of polymorphonuclear and mononuclear 
cell infiltrates, and a reduction in the amount of super-
ficial mucosa damage. Prolonged hyperproliferation of 
the gastric epithelium exerted by HP infection could be 
a major factor for human gastric carcinogenesis. 
INTRODUCTION 
Gastritis associated with Helicobacter pylori (HP) 
infection is among the most frequent chronic infectious 
diseases in the world. Its estimated prevalence in adults 
varies from approximately 30% to near 100% in differ-
ent populations (1-3). According to some authors, the 
syndrome most frequently related to HP infection is 
non-ulcer dyspepsia (4, 5). The bacterium is also con-
sidered a contributing cause of peptic ulcer and gastric 
carcinoma (2, 6-11). 
Because the bacterium colonizes the gastric lumen 
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but does not invade the tissues, the mechanisms of 
tissue damage are the subject of scientific scrutiny. 
Cellular damage due to bacterial cytotoxin (12) and to 
ammonia produced by its potent urease have been 
implicated (13). The mechanism of its putative carcin-
ogenic effect is unknown. This report explores the 
hypothesis that excessive cell replication, a factor of 
major relevance in carcinogenesis (14, 15), may be 
caused in the gastric mucosa by HP infection. Cell 
replication is assessed in this study by the effect of HP 
eradication on the expression of proliferating cell nu-
clear antigen (PCNA). 
MATERIALS AND METHODS 
Fifty-eight patients referred for upper gastrointestinal 
endoscopy at Charity Hospital in New Orleans, with a 
clinical and endoscopic diagnosis of non-ulcer dyspep-
sia, were included in this study. Each agreed to partic-
ipate in a longitudinal study of the effects of HP on 
gastric histopathology, approved by the Louisiana State 
University Institutional Review Board. Eleven patients 
who were found to have normal gastric mucosa were 
negative for HP. These subjects had only one visit and 
were used as controls. The rest of the patients had 
gastroscopic biopsies positive for HP on rapid urease 
test (16) and were invited to participate in the study. 
The subjects were assigned treatments after the first 
visit as follows: 13 received no specific treatment for 
HP, 23 received triple therapy consisting of: 1) bismuth 
subsalicylate (262 mg qid for 28 days), 2) metronida-
zole (500 mg qid on days 18-28), and 3) amoxycyllin 
(500 mg qid on days 8-24); and 11 patients received 
triple therapy with nitrofurantoin (100 mg qid on days 
8-17) instead of amoxycyllin. Endoscopies and biopsies 
were repeated on the second visit as follows. In those 
who received triple therapy, the mean time from ter-
mination of treatment to second biopsy was 3 days 
(range 12 h to 23 days), with a median of 1 day. In this 
group, 10 patients had a second biopsy 12 h after 
finishing treatment, and 24 patients had a second bi- 
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opsy 36 h or more after finishing treatment. Patients 
who received no specific treatment for HP had a second 
biopsy after a mean of 147 days (range 56-226 days), 
and a median of 168 days. 
Five antral biopsies and one corporal biopsy were 
taken on each visit. One antral biopsy, from the lesser 
curvature, was used for the rapid urease test for HP. 
Two antral biopsies (greater and lesser curvature) were 
fixed in 95% alcohol, and two (greater and lesser cur-
vature) were fixed in 10% buffered formalin. The cor-
poral biopsy was also fixed in 10% buffered formalin. 
Tissues were dehydrated and paraffin embedded, sec-
tioned at 3 Am and placed on poly-L-lysine (Sigma 
Chemical Co.) -coated glass slides. The formalin-fixed 
tissues were stained with hematoxylin and eosin, 
periodic acid-Schiff-Alcian blue (PAS-AB) pH 2.5 (17), 
and the Steiner modification of Warthin-Starry staining 
for HP (18). 
The 95% alcohol fixed tissues were immunostained 
for PCNA with PC10 monoclonal antibody (Dako Cor-
poration), by a microwave-assisted streptavidin-biotin 
peroxidase method, and the Fisher Capillary System 
(Fisher Scientific). This method allowed us to immu-
nostain 60 slides at the same time, under the same 
conditions for antibody incubation. Briefly, sections 
were deparaffinized and rehydrated. Endogenous per-
oxidase was blocked with 3% hydrogen peroxide for 10 
s in a microwave oven at high power (1440 watts). After 
washing in deionized water, sections were boiled 6 min 
in deionized water in the microwave oven at high power 
and allowed to stand for 3 min (19). Sections were 
placed in the Capillary System slide holder and washed 
in phosphate-buffered saline (PBS) (pH 7.2) with 0.01% 
Tween 20 (Sigma) 3 times for 10 s, then were drained 
over a thick paper pad. All the antibody incubations 
were done in the microwave oven at 30% power and 
allowed to stand for 3 min. PC10 monoclonal antibody 
was incubated for 14 min. Secondary biotinylated goat 
antimouse immunoglobulins (Dako) was incubated for 
7 min. Streptavidin-peroxidase complex (Dako) was 
incubated for 7 min. Diaminobenzidine (Sigma) was 
used at 0.05% in PBS for 10 min at room temperature. 
Sections were lightly counterstained with Harris he-
matoxylin, dehydrated, and mounted. Negative con-
trols included substitution of primary antibody with 
PBS or normal mouse serum. 
A Joyce-Loebl Magiscan (London, England) image 
analysis system was used to assess the PCNA nuclear 
labeling. PCNA was evaluated in areas corresponding 
to gastric antrum glandular necks at x400, using a 
static 560-nm filter. Seven glandular necks were se-
lected at random in each specimen to ensure a mini-
mum of 250 total nuclei. System thresholding was 
adjusted so only those nuclei stained a strong dark 
brown were counted as positive. Then, the threshold  
was adjusted to count the total nuclei in the selected 
areas. The mean number of nuclei counted per speci-
men was 508 (range 267-752, median 526). The PCNA 
labeling index (PCNA LI) was defined as a percentage 
of the PCNA-positive nuclei over the total nuclei in 
glandular neck regions. 
Biopsies were diagnosed histopathologically accord-
ing to previously defined criteria (20) in diffuse antral 
gastritis (DAG) and multifocal atrophic gastritis (MAG) 
on formalin-fixed and hematoxylin and eosin-stained 
sections of corpus and antrum. DAG is characterized 
by a dense infiltrate of lymphocytes and plasma cells 
occupying the full thickness of the antral mucosa. The 
infiltrate expands the lamina propria, separating the 
gastric glands, and lymphoid follicles may be promi-
nent; this entity is most often related to the duodenal 
ulcer syndrome. MAG corresponds to multifocal glan-
dular atrophy accompanied by an inflammatory mono-
nuclear infiltrate, and is located in antrum and body. 
Intestinal metaplasia is often found associated with 
MAG. A semiquantitative assessment of the histopath-
ologic changes was made by two observers; discrepan-
cies were resolved by consensus after joint review. The 
presence of polymorphonuclear and mononuclear cells 
in the lamina propria and glands was evaluated as 0 = 
normal or very rare, 1 = a few or equivocal, 2 = 
moderate number, and 3 = marked increase. Damage 
to superficial and foveolar epithelia, along with mucus 
depletion, was evaluated in both hematoxylin and eosin 
and PAS-AB, and given the following scores: 0 = nor-
mal superficial mucosa, 1 = mild superficial mucosa 
damage, 2 = moderate superficial mucosa damage, and 
3 = marked superficial mucosa damage. The presence 
of HP was scored accordingly, 0 = negative, 1 = small 
number, 2 = moderate number, and 3 = abundant. A 
global histological score, adding all the previous param-
eter scores except for HP, was used for comparison. 
All of the slides were evaluated blindly, without 
previous knowledge of the histological diagnosis, treat-
ment, or treatment outcome for HP. PCNA LI was 
evaluated only in non-metaplastic areas. 
Student's t test (two-tailed) was used to evaluate pre-
and post-treatment differences in PCNA LI. Compari-
son of histopathological scores was performed by Wil-
coxon's rank test (two-tailed). 
RESULTS 
The study included 39 females and 19 males, with a 
mean age of 47.7 yr (range 20-70). Histological diag-
nosis included 40 patients with MAG, seven with DAG, 
and 11 normal gastric biopsies used as controls. 
Immunostaining of PCNA, with a diffuse granular 
pattern, was localized in the nuclei. The staining inten-
sity was variable. In the normal cases, strong labeling 
was observed only in the glandular necks (Fig. 1A). 
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FIG. 1. PCNA immunostaining of the gastric mucosa. A, normal 
gastric mucosa expressing PCNA in the nuclei of cells of the glandular 
necks (x200). B, MAG, showing an increased number of PCNA-
positive nuclei and extension to superficial and deep areas of the 
mucosa (x200). 
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Some of these cases had weak staining in a few cells of 
the superficial mucosa. In chronic gastritis, strong nu-
clear PCNA immunostaining was observed mainly in 
glandular necks (Fig. 1B), but in some cases, few stained 
nuclei were seen in the deep or superficial areas of the 
mucosa. The PCNA stain was evaluated only in glan-
dular necks. The few positively stained nuclei in other 
layers were insufficient for adequate evaluation. 
The 11 patients with normal gastric histology and 
negative for HP showed a mean PCNA LI of 13.05 ± 
1.70 (Table 1). On the second visit, of the 47 patients 
initially positive for HP, 31 cleared and 16 persisted 
with the infection. In patients who remained HP posi-
tive, the PCNA LI did not change significantly (Table 
1). The mean PCNA LI for those who cleared HP 
decreased significantly (p < 0.001). Patients who re-
mained positive for HP, on both the first and second 
visit, showed a significantly higher PCNA LI than nor-
mal control biopsies (p < 0.05). However, patients who 
cleared HP infection showed a significantly higher 
PCNA LI only on the first visit, in relation to normal 
gastric mucosa (p < 0.01). 
According to histopathological diagnosis, patients 
with MAG, whose HP cleared, showed a significant 
reduction in PCNA LI (n = 19, 22.10 ± 2.61 vs. 15.09 
± 1.33, p < 0.05), and those that did not clear showed 
no difference (n = 16, 20.71 ± 2.65 vs. 19.51 ± 1.97). 
In DAG, five patients cleared HP and showed a tend-
ency to maintain similar PCNA LI (17.85 ± 3.52 vs. 
16.90 ± 5.69); two patients did not clear, but were not 
sufficient for statistical analysis. 
Histopathological parameters were evaluated by the 
system of scores described above. In patients who 
cleared HP, there was a significant reduction of the 
inflammatory, infiltrate, reflected in the scores for pol-
ymorphonuclear and mononuclear cell infiltration (p 
< 0.001) (Table 2). A significant improvement in the 
mucus production (p < 0.001) was observed in those 
patients who cleared HP. These improvements after HP 
clearance were reflected in the significant reduction of 
the global histopathological score (p < 0.001). Histo-
pathological parameters in patients who remained pos-
itive did not change significantly. 
Table 3 displays the PCNA LI on the second visit, 
according to the histologic parameters studied and HP 
TABLE 1 
PCNA Labeling Index* According to Study Results 
First Visit Second Visit p 
HP cleared (n = 31) 19.95 ± 1.77 14.13 ± 1.29 <0.001 
HP persisted (n = 16) 18.95 ± 1.71 17.96 ± 1.91 NSt 
Nl. histology, HP -ye 
(n = 11) 
13.05 ± 1.70 
* Mean ± SEM. 
t NS, not statistically significant. 
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TABLE 2 
Comparison of Scores for Histological Parameters and Helicobacter pylori Status 
Parameter 
HP Cleared 
(n = 31) 
 
HP Persisted 
(n = 16) 
    
First visit 
	 Second visit First visit 	 Second visit 
Median score p Median score p 
Sup. mucosa dam. 2 0 <0.001 1 2 NS 
PMN cells 2 0 <0.001 2 2 NS 
MN cells 2 1 <0.001 2 2 NS 
Histol. score 7 3 <0.001 6 7 NS 
Abbreviations: Sup. mucosa dam, superficial mucosa damage; PMN, polymorphonuclear; MN, mononuclear; NS, not statistically significant. 
TABLE 3 
PCNA LI* According to Histologic Parameters and HP Status on Second Visit 
All Observations 
(n = 58) 
HP Positive 
(n = 16) 
HP Negative 
(n = 31) 
PMN infiltrate 
Absent or mild (46) 13.91 ± 0.99 (4) 14.53 ± 3.40 (31) 14.13 ± 1.29 
Moderate or severe (12) 19.11 ± 2.26 (12) 19.11 ± 2.26 (0) 
p = 0.024 p = 0.316 ISS 
MN infiltrate 
Absent or mild (33) 13.90 ± 1.25 (4)  14.53 ± 3.40 (18) 14.27 ± 1.97 
Moderate or severe (25) 16.41 ± 1.41 (12) 19.11 ± 2.26 (13) 13.93 ± 1.51 
p = 0.190 p = 0.316 p = 0.898 
Sup. mucos. dam. 
No depletion (45) 13.90 ± 0.99 (5)  12.04 ± 2.41 (29) 14.54 ± 1.34 
Some depletion (13) 18.73 ± 2.23 (11) 20.65 ± 2.15 (2) 8.18 ± 0.78 
p = 0.031 p = 0.031 ISS 
Results are expressed as mean ± SEM. Number of patients in parentheses. PMN, polymorphonuclear cells; MN, mononuclear cells; Sup. 
mucos. dam., superficial mucosa damage; ISS, insufficient sample size. 
status. If the whole study group is considered, those 
patients with a moderate or severe polymorphonuclear 
cell infiltrate and those with superficial mucosa damage 
showed a significantly higher PCNA LI. In the whole 
group, and in those positive for HP, the greater intensity 
of the mononuclear infiltrate was associated with a 
tendency to a higher LI, but it did not reach statistical 
significance. After clearance of HP, the PCNA LI did 
not differ significantly according to the intensity of 
mononuclear infiltrate. In the group that cleared HP, 
both the polymorphonuclear infiltrate and the superfi-
cial mucosa damage disappeared, making impossible 
their independent evaluation. 
DISCUSSION 
The value of PCNA LI in assessing cell proliferation 
is supported by studies of carcinoma of the stomach 
showing a good correlation with S + G2M phase of flow 
cytometric analysis (21) and with Ki-67 (22). In other 
systems, PCNA LI has shown a good correlation with 
other indexes of cell proliferation such as [3H]thymidine 
(23, 24), and bromodeoxyuridine (BrdUrd) (24, 25). 
PCNA is mainly expressed in late G1 phase, during the 
S phase and early G2 (26), and it can be detected at  
low levels in cells during the cell cycle. PCNA LI, 
compared with BrdUrd and flow cytometry, has shown 
a higher percentage of proliferating cells (22, 23, 27). 
One explanation offered for these results is the long 
half-life of PCNA (about 20 h) (28). Image analysis 
thresholding has allowed us to select only those nuclei 
that are strongly positive, which has been reported to 
have a better correlation with BrdUrd and flow cytom-
etry cell proliferation indices (29, 30). PCNA reportedly 
had a better correlation with [3H]thymidine labeling 
when alcohol-fixed tissues were used (23, 27, 29, 30). 
Cell proliferation studies in chronic gastritis have 
shown a high number of proliferating cells (31, 32), 
consistently higher than the normal gastric mucosa. 
There have been similar findings on colonic mucosa, 
in which a state of hyperproliferation is present in 
precancerous conditions such as familial polyposis, ad-
enomas, and ulcerative colitis (33-36). 
Our study shows a significant reduction of PCNA-
labeled cells, indicative of cell replication, after clear-
ance of HP. The post-clearance indices are very close 
to those of the normal gastric mucosa. These results 
indicate that the infected gastric mucosa is in a state of 
hyperproliferation. 
Histopathological parameters were improved after 
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HP eradication in our study. Both acute and chronic 
inflammatory infiltrates were reduced in significant 
numbers. Superficial mucosa damage and mucus de-
pletion were significantly attenuated after HP clearance. 
These changes corroborate those observed by others 
(37-40) and confirm the damage inflicted by HP on 
the gastric mucosa. Changes in the chronic (lympho-
cytic) infiltrate need to be studied for a longer term. 
Given the chronicity of the gastritis, it is probable 
that the state of hyperproliferation is present for many 
years in most patients. Because HP infection increases 
gastric cancer risk, this situation fits the hypothesis 
proposed by Ames and others (41, 42) that in a hyper-
proliferative state, endogenous ("spontaneous") muta-
tions may induce genetic lesions which accumulate and 
eventually might lead to neoplastic transformation (43, 
44). Helicobacter-associated gastritis provides a model 
to use to examine this hypothesis, because persistence 
of hyperproliferation over a long period of time is 
associated with an increased risk of carcinoma (2, 8, 6, 
45, 46). According to the Ames hypothesis, endogenous 
mutations per se, without external mutagens or carcin-
ogens, may be sufficient to induce neoplastic changes 
in tissues in a state of hyperproliferation (42). 
In populations at high risk of gastric carcinoma, the 
prevalence of Helicobacter-associated gastritis is very 
high (2, 8, 6, 45, 46). The type of gastritis predominant 
in such populations is the so called multifocal atrophic 
gastritis (MAG), as it happens in the New Orleans 
blacks, who predominate in our study (12). Mucosal 
atrophy is followed by intestinal metaplasia and, even-
tually, dysplasia and carcinoma (47). Helicobacter in-
fection is very prevalent and severe in such populations, 
which strongly suggests a causative role for the bacteria 
in carcinogenesis (9). 
HP, however, is also prevalent in DAG, which is the 
predominant type of gastritis in populations at low 
gastric cancer risk, such as the white middle-class Amer-
icans (9). DAG is also the predominant type of gastritis 
seen in children. Recent studies in Costa Rica compared 
the prevalence of gastritis and Helicobacter infection in 
children from the central plateau (who have some of 
the highest gastric cancer risks on record), with those 
from the coastal lowlands, where the gastric cancer risk 
is low (48). In both populations the prevalence of HP-
associated gastritis is very high: around 70% in children 
of 7-12 yr of age. Because the gastritis in the coastal 
lowlands is not associated with higher cancer risk, it 
follows that HP is not a sufficient cause of gastric 
cancer. Other factors, presumably present in the plateau 
highlands, are needed and may probably be more effec-
tive in the presence of the hyperproliferative state 
brought about by HP infection. The same pattern of 
high prevalence of HP-associated chronic gastritis but 
low gastric cancer risk is observed in Africa (3). These  
AJG - Vol. 88, No. 11, 1993 
observations suggest that endogenous mutations per se 
are not sufficient to increase the cancer rates to epi-
demic proportions. 
Our studies indicate that prolonged hyperprolifera-
tion of the gastric epithelium is a major mechanism by 
which HP exerts a contributing causal influence in 
human gastric carcinogenesis. 
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